Visualitza per autor "De Giorgi, Ugo"
Ara mostrant els elements 1-2 d 2
-
Effect of Baseline Characteristics on Cabazitaxel Treatment Duration in Patients with Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the Compassionate Use/Expanded Access Programs and CAPRISTANA Registry
Malik, Zafar; Di Lorenzo, Giuseppe; Pichler, Angelika; Hitier, Simon; Ecstein-Fraisse, Evelyne; Carles Galceran, Joan; De Giorgi, Ugo (MDPI, 2020-04-17) -
First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial
Fizazi, Karim; Fay, Andre P; De Giorgi, Ugo; Azad, Arun; Carles, Joan; Matsubara, Nobuaki (Nature Portfolio, 2024-01)